cardiac

Teams focused on cell therapy and diagnostics win first and second place at the Building a Biotech Venture Pitch Competition

Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition

New Medicine by Design-supported research shows mature heart cells perform well in transplants

Study is an important step forward in researchers’ understanding of treating damaged hearts with cell therapies.

Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap

Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.

Go to Top